ISIN | CH0009699411 |
---|---|
Valor Number | 969941 |
Bloomberg Global ID | |
Fund Name | Unigestion Swiss Equities A |
Fund Provider |
Unigestion
Genève 12, Switzerland Phone: +41 22 704 41 11 Web: www.unigestion.com |
Fund Provider | Unigestion |
Representative in Switzerland | |
Distributor(s) |
Unigestion S.A. Genève 12 Phone: +41 22 704 41 11 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Special conditions apply to the issue of units |
Redemption Condition | Special conditions apply to the redemption of units |
Investment Strategy *** | The main objective of the fund is to achieve a long term performance equal to,or greater than,the SMI index,with a lower volatility while controlling the tracking error of the portfolio.This is achieved by using a quantitative method based on the construction of a "minimum variance" portfolio,i.e. the optimal portfolio having the lowest expected volatility or risk. |
Peculiarities |
Current Price * | 2,508.16 CHF | 04.07.2024 |
---|---|---|
Previous Price * | 2,500.08 CHF | 03.07.2024 |
52 Week High * | 2,528.23 CHF | 07.06.2024 |
52 Week Low * | 2,244.80 CHF | 23.10.2023 |
NAV * | 2,508.16 CHF | 04.07.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 78,866,140 | |
Unit/Share Assets *** | 1,666,237 | |
Trading Information SIX |
YTD Performance | +7.44% |
29.12.2023 - 04.07.2024
29.12.2023 04.07.2024 |
---|---|---|
1 month | +0.81% |
04.06.2024 - 04.07.2024
04.06.2024 04.07.2024 |
3 months | +4.01% |
04.04.2024 - 04.07.2024
04.04.2024 04.07.2024 |
6 months | +6.13% |
04.01.2024 - 04.07.2024
04.01.2024 04.07.2024 |
1 year | +4.66% |
04.07.2023 - 04.07.2024
04.07.2023 04.07.2024 |
2 years | +7.27% |
04.07.2022 - 04.07.2024
04.07.2022 04.07.2024 |
3 years | -3.04% |
05.07.2021 - 04.07.2024
05.07.2021 04.07.2024 |
5 years | +17.33% |
04.07.2019 - 04.07.2024
04.07.2019 04.07.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 11.72% | |
---|---|---|
Nestle SA | 11.54% | |
Roche Holding AG | 8.23% | |
Zurich Insurance Group AG | 7.57% | |
Compagnie Financiere Richemont SA Class A | 5.92% | |
Swiss Re AG | 5.25% | |
Swisscom AG | 3.61% | |
UBS Group AG | 3.49% | |
Galenica Ltd. | 3.23% | |
Swiss Prime Site AG | 3.04% | |
Last data update | 31.05.2024 |
TER | 1.36% |
---|---|
TER date | 31.03.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.30% |
Ongoing Charges *** | 1.36% |
SRRI ***
|
|
SRRI date *** | 30.06.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |